4Vande Kerkhove M P, Hoekstra R,Chamu|eau R A, et al. Clinical application of bioartificial liver support systems [ J ]. Ann Surg, 2004,240(2) :216 -230.
3Koelen MA,Vaandrager L,Colomér C.Health promotion research:dilemmas and challenges.J Epidemiol Community Health,2001,55:257
4Green J.The role of theory in evidence based health promotion practice.Health Educ Res,2000,15:125
5Gabon PA.The spectrum of rhabdomyolysis[J].Medicine,1982,62:141-152.
6Harris K,Walker PM,Mickle DA,et al.Metabolic response of skeletal muscle to ischemia[J].Am J Physiol,1986,250:H213-220.
7Roberts JP,Perry MO,Hariri RJ,et al.Incomplete recovery of muscle cell function following partial but not complete ischemia[J].Circ Shock,1985,17:253-258.
9Wappler F,Fiege M,Steinfath M,et al.Evidence for suscep tibility to malignant hyperthermia in patients with exercise induced rhabdomyolysis[J].Anesthesiology,2001,94:95-100.
10Bellomo R,Baldwin I,Cloe L,et al.Preliminary experience with highvolume hemofilatation in human septic shock[J].Kidey Int,1998,53:S182.
